英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
(2R)-(3-hydroxyfund-1-yl)({[(2-methyl-2-propaneyl)oxy]carbonyl}amino)acetic acid |
(2R)-(3-羥基金剛烷-1-基)({[((2-甲基-2-丙烷基)氧基]羰基}氨基)乙酸 |
709031-29-8 |
詳細(xì)
|
(1R,3R,5R)-2-azabicyclo[3.1.0]hexane-3-carboxamide methylsulfonate |
(1R,3R,5R)-2-氮雜雙環(huán)[3.1.0]己烷-3-甲酰胺甲基磺酸鹽 |
1312338-82-1 |
詳細(xì)
|
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid trifluoroacetate |
(1S,3S,5S)-2-氮雜雙環(huán)[3.1.0]己烷-3-羧酸三氟乙酸鹽 |
1523541-80-1 |
詳細(xì)
|
(1R,3S,5R)-2-azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate |
(1R,3S,5R)-2-氮雜雙環(huán)[3.1.0]己烷-3-甲酰胺甲基磺酸鹽 |
1564266-70-1 |
詳細(xì)
|
(1S,3R,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate |
(1S,3R,5S)-2-氮雜雙環(huán)[3.1.0]己烷-3-甲酰胺甲基磺酸鹽 |
1567266-74-5 |
詳細(xì)
|
1,N-Methyl-N-nitrosoamino-1-deoxy-D-glucitole |
1-N-甲基-N-亞硝基氨基-1-脫氧-D-葡萄糖醇 |
10356-92-0 |
詳細(xì)
|
Cevelestat sodium impurity C-4 (2-(anthramide)benzoic acid) |
西維來(lái)司他鈉雜質(zhì)C-4(2-(鄰氨基苯甲酰胺)苯甲酸) |
612-34-0 |
詳細(xì)
|
Cevelestat sodium impurity C-2 (anthranilic acid) |
西維來(lái)司他鈉雜質(zhì)C-2(鄰氨基苯甲酸) |
552-37-4 |
詳細(xì)
|
Lumateperone Impurity 6 |
盧美哌降雜質(zhì)6 |
313368-82-0 |
詳細(xì)
|
Tributylphosphine oxide |
三正丁基氧化磷 |
814-29-9 |
詳細(xì)
|
3,3'-Bipyridine |
3,3'-聯(lián)吡啶 |
581-46-4 |
詳細(xì)
|
Caspofungin C0 control |
卡泊芬凈C0對(duì)照品 |
135575-42-7 |
詳細(xì)
|
Impurity A (simvastatin hydroxy acid) |
雜質(zhì)A(辛伐他汀羥基酸) |
139893-43-9 |
詳細(xì)
|
DiMethylsilanediol |
二甲基硅烷二醇 |
1066-42-8 |
詳細(xì)
|
5-(3-(2,5-Dichloro-4,6-dimethylpyridin-3-yl)-1,2,4-oxadiazol-5-yl)-3-nitrobenzene-1,2-diol |
2,5-二氯-3-[5-(3,4-二羥基-5-硝基苯基)-1,2,4-噁二唑-3-基]-4,6-二甲基吡啶 |
952091-17-7 |
詳細(xì)
|
2,5-Dichloro-3-[5-(3,4-dimethoxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl]-4,6-dimethylpyridine-1-oxide |
2,5-二氯-3-[5-(3,4-二甲氧基-5-硝基苯基)-1,2,4-噁二唑-3-基]-4,6-二甲基吡啶-1-氧化物 |
2356241-51-3 |
詳細(xì)
|
Edoxaban RSR Isomer |
依度沙班RSR異構(gòu)體 |
1255529-23-7 |
詳細(xì)
|
BZSM2-E |
3-(2-氯苯基)-5-甲基-4-異惡唑甲酰氯 |
25629-50-9 |
詳細(xì)
|
(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate tert-butyl ester |
(1S,3S,5S)-3-氨基甲酰-2-氮雜雙環(huán)[3.1.0]己烷-2-甲酸叔丁酯 |
361440-67-7 |
詳細(xì)
|
(2S)-adamantane-1-yl ({[((2-methyl-2-propaneyl)oxy]carbonyl}amino}acetic acid |
(2S)-金剛烷-1-基({[((2-甲基-2-丙烷基)氧基]羰基}氨基}乙酸 |
361441-97-6 |
詳細(xì)
|
Gadolinium cloth alcohol intermediate I |
釓布醇中間體I |
156077-56-4 |
詳細(xì)
|
Gadolinium cloth alcohol intermediateII |
釓布醇中間體II |
138168-36-2 |
詳細(xì)
|
Gadolinium cloth alcohol intermediate II impurity 8 |
釓布醇中間體II雜質(zhì)8 |
2514736-58-2 |
詳細(xì)
|
PLL-OX control |
PLL-OX對(duì)照品 |
52549-19-6 |
詳細(xì)
|
Bilastine Impurity IM01-2 |
比拉斯汀雜質(zhì)IM01-2 |
|
詳細(xì)
|
2-(tert-Butylamino)-3',5'-dichloropropiophenone Hydrochloride |
安非他酮雜質(zhì) |
1346603-00-6 |
詳細(xì)
|
Methanone, [4-(2-aminoethyl)phenyl]phenyl-, hydrochloride (9CI) |
多巴胺雜質(zhì) |
16362-98-4 |
詳細(xì)
|
(E)-2-cyano-3-morpholin-4-ylprop-2-enamide |
Z-2-氰基-3-(1,4-氧雜氨雜環(huán)己-4-基)丙-2-烯酰胺 |
159832-22-1 |
詳細(xì)
|
N,N-Dinitrosopyrrolopiperidine |
N,N-二亞硝基吡咯并哌啶 |
|
詳細(xì)
|
N-hydroxypropranolol |
普萘洛爾N-氧化物 |
84418-31-5 |
詳細(xì)
|
4-(3-chloro-4-(formylethyl)phenoxy)phenoxy]-7-methoxy-6-quinoline carboxylic acid |
4-(3-氯-4-(甲酰乙酯)苯氧基)苯氧基]-7-甲氧基-6-喹啉羧酸 |
|
詳細(xì)
|
(3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethylpropane)-1-cyclohexen-1-carboxylic acid ethyl ester phosphate |
(3R,4R,5S)-4-乙酰氨基-5-氨基-3-(1-乙基丙氣基)-1-環(huán)已烯-1-羧酸乙酯磷酸鹽 |
|
詳細(xì)
|
Desloratadine Epoxide |
地氯雷他定雜質(zhì)K |
1346604-23-6 |
詳細(xì)
|
Betalmethasone chloride |
倍他米松氯化物 |
116846-77-6 |
詳細(xì)
|
Cevelestat sodium impurity B-3 (valeanhydride) |
西維來(lái)司他鈉雜質(zhì)B-3(特戊酸酐) |
1538-75-6 |
詳細(xì)
|
N-ethylpipelethylamine hydrochloride |
N-乙基胡椒乙胺 鹽酸鹽 |
|
詳細(xì)
|
Glycine, N-[(4-hydroxy-7-phenoxy-3-isoquinolinyl)carbonyl]- |
N-[(4-羥基-7-苯氧基-3-異喹啉)羰基]甘氨酸 |
708263-68-7 |
詳細(xì)
|
1-Methyl-4-hydroxy-7-phenoxyisoquinoline-3-carboxylic acid |
1-甲基-4-羥基-7-苯氧基異喹啉-3-甲酸 |
1421312-35-7 |
詳細(xì)
|
4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxamide |
1-甲基-4-羥基-7-苯氧基異喹啉-3-甲酰胺 |
2243809-28-9 |
詳細(xì)
|
2,2'-(1H,1'-H-[3,3'-bisindazole]-6,6'-diylbis(sulfadiyl))bis(N-methylbenzamide) |
2,2'-(1H,1'-H-[3,3'-雙吲唑]-6,6'-二基雙(磺胺二基))雙(N-甲基苯甲酰胺) |
|
詳細(xì)
|
N-Methyl-2-(2-oxopyrrolidin-1-yl)acetamide |
N-甲基-2-(2-氧代吡咯烷-1-基)乙酰胺 |
|
詳細(xì)
|
ZOLPIDEM IMPURITY A |
唑吡坦雜質(zhì) A |
1346600-85-8 |
詳細(xì)
|
Finerenone impurity 69 |
非奈利酮雜質(zhì)69 |
|
詳細(xì)
|
Upadacitinib Impurity 21 |
烏帕替尼雜質(zhì)21 |
1428243-69-9 |
詳細(xì)
|
Upadacitinib Impurity 30 |
烏帕替尼雜質(zhì)30 |
|
詳細(xì)
|
Mirogabalin besylateM1-Impurity A |
苯磺酸美洛加巴林M1-雜質(zhì)A |
|
詳細(xì)
|
Ilaprazole Impurity J |
艾普拉唑雜質(zhì)J |
|
詳細(xì)
|
Fosfomycin Impurity 17 |
磷霉素雜質(zhì)2 |
856609-47-7 |
詳細(xì)
|
5-(sec-butoxy)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid |
5-仲丁氧基-4-(4-氰基-2-甲氧基苯基)-2,8-二甲基-1,4-二氫-1,6-萘啶-3-甲酸 |
|
詳細(xì)
|
Fmoc- Val - Val –OH |
(2S)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanamido]-3-methylbutanoic acid |
116460-32-3 |
詳細(xì)
|
NA |
RD-2023008-雜質(zhì)P3-6 |
|
詳細(xì)
|
Benzyl (3S,4R)-3-ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate |
RD-2023008-雜質(zhì)P3-1 |
1708997-42-5 |
詳細(xì)
|
1-Methyl-1H-pyrrole-2(5H)-one |
托氟沙星雜質(zhì)1 |
13950-21-5 |
詳細(xì)
|
NA |
托氟沙星雜質(zhì)3 |
|
詳細(xì)
|
NA |
托氟沙星雜質(zhì)5 |
|
詳細(xì)
|
Levalbuterol Related Compound G (20 mg) (alpha[{(1,1-Dimethylethyl)amino}methyl]-4,5-dihydroxy-1,3-benzenedimethanol) |
沙丁胺醇雜質(zhì)S |
182676-90-0 |
詳細(xì)
|
Rosuvastatin calcium impurity FP-B |
瑞舒伐他汀鈣雜質(zhì)FP-B |
|
詳細(xì)
|
Baloxavir Marboxil Impurity 10 |
巴洛沙韋酯雜質(zhì)10 |
|
詳細(xì)
|
Levosimondanan impurity 1-3 control |
左西孟旦雜質(zhì)1-3對(duì)照品 |
|
詳細(xì)
|
2-(2-(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3carbonyl)amino)-acetylamino)acetic acid |
2-(2-((4-羥基-1-甲基-7-苯氧基異喹啉-3羰基)氨基)-乙酰氨基)乙酸 |
|
詳細(xì)
|
2,3-dimethyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium |
2,3-二甲基-4-(2,2,2-三氟乙基)吡啶-N-氧化物(SMB-04) |
103577-61-3 |
詳細(xì)
|
(2S,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol |
(2S,3R)-2-(2,4-二氟苯基)-1-(1H-1,2,4-三唑-1-基)-2,3-丁二醇 |
135272-36-5 |
詳細(xì)
|
[(1-methyl-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid-2-nitrogen oxide |
[(1-甲基-4-羥基-7-苯氧基異喹啉-3-羰基)氨基]乙酸-2-氮氧化物 |
|
詳細(xì)
|
Crisaborole Impurity C |
克立硼羅雜質(zhì)C |
2803552-55-6 |
詳細(xì)
|
[3-(4-cyanophenoxy)phenyl]methyl acetate |
克立硼羅脫溴雜質(zhì) |
2990481-66-6 |
詳細(xì)
|
Naltrexone hydrochloride |
鹽酸納曲酮 |
16676-29-2 |
詳細(xì)
|
Isopropylmethansulfonat |
甲磺酸異丙酯 |
926-06-7 |
詳細(xì)
|
2,6-Dimethyl-2,5-heptadien-4-one |
佛爾酮 |
504-20-1 |
詳細(xì)
|
Dapoxetine hydrochloride impurity C |
鹽酸達(dá)泊西汀雜質(zhì)C |
100306-33-0 |
詳細(xì)
|
Dapoxetine hydrochloride impurity B |
鹽酸達(dá)泊西汀雜質(zhì)B |
156453-53-1 |
詳細(xì)
|
3-Deoxy-glyceropentantulose |
3-脫氧-甘油戊酮糖 |
3343-53-1 |
詳細(xì)
|
Avibactam sodium |
阿維巴坦納對(duì)照品 |
1192491-61-4 |
詳細(xì)
|
Avibactam sodium impurity 20 |
阿維巴坦鈉雜質(zhì) 20 |
1383814-68-3 |
詳細(xì)
|
Phenytoin Impurity E |
苯妥英鈉雜質(zhì)E |
6802-95-5 |
詳細(xì)
|
Phenytoin Impurity D |
苯妥英鈉雜質(zhì)D |
5157-15-3 |
詳細(xì)
|
Impurity D (3,4-dimethoxychalcone related compound A) |
雜質(zhì)D(3,4-二甲氧基查耳酮相關(guān)化合物A) |
107257-20-5 |
詳細(xì)
|
(3R,4R,5S)-5-Acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid |
(3R,4R,5S)-5-乙酰氨基-4-氨基-3-(1-乙基丙氧基)-環(huán)已-1-烯-1-羧酸 |
1364932-19-3 |
詳細(xì)
|
Tafluprost Impurity 3 |
他氟前列素雜質(zhì)3 |
2920059-96-5 |
詳細(xì)
|
Landiolol Impurity |
蘭地洛爾雜質(zhì) |
64704-12-7 |
詳細(xì)
|
4-[(2,2-Dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidenemethyl)-amino]-2-methoxy-benzoic acid methyl ester |
4-((2,2-二甲基-4,6-二氧代-1,3-二噁烷-5-基)甲基氨基)-2-甲氧基苯甲酸甲酯 |
205448-64-2 |
詳細(xì)
|
3-Amino-4-chlorophenol |
3-氨基-4-氯苯酚 |
16026-77-0 |
詳細(xì)
|
4-amino-3,5-dichlorophenol |
4-氨基-2,3-二氯苯酚 |
26271-75-0 |
詳細(xì)
|
4-Chloro-7-methoxy-N,N-dimethylquinoline-6-carboxamide |
4-氯-7-甲氧基-N,N-二甲基喹啉-6-甲酰胺 |
417723-66-1 |
詳細(xì)
|
Rosuvastatin Impurity J |
瑞舒伐他汀鈣雜質(zhì)J |
2226413-62-1 |
詳細(xì)
|
2-Cyanoethyl 3-oxobutanoate |
2-氰基乙酰乙酸乙酯 |
65193-87-5 |
詳細(xì)
|
Esomeprazole EP Impurity C |
艾司奧美拉唑EP雜質(zhì)C |
73590-85-9 |
詳細(xì)
|
Esomeprazole Impurity G |
艾司奧美拉唑鎂雜質(zhì)G |
125656-83-9 |
詳細(xì)
|
Esomeprazole Impurity I |
艾司奧美拉唑鎂雜質(zhì)I |
158812-85-2 |
詳細(xì)
|
2-{[6-amino-5-(4-bromophenyl)pyrimidin-4-yl]oxy}ethan-1-ol |
2-((6-氨基-5-(4-溴苯基)嘧啶-4-基)氧基)乙烷-1-醇 |
2211059-05-9 |
詳細(xì)
|
2,2'-[ethane-1,2-diylbis(oxy)]bis(5-bromopyrimidine) |
2,2’-[乙烷-1,2-二基雙(氧)]雙(5-溴嘧啶) |
2211054-90-7 |
詳細(xì)
|
Ilaprazole Impurity H |
艾普拉唑雜質(zhì)H |
|
詳細(xì)
|
Ilaprazole Impurity F |
艾普拉唑雜質(zhì)F |
|
詳細(xì)
|
Paliperidone Impurity 81 |
帕利哌酮雜質(zhì)7(E構(gòu)型) |
691007-07-5 |
詳細(xì)
|
1-(4-((3R,5R)-5-(1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-4-nitrosopiperazine |
1-(4-((3R,5R)-5-(1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)苯基)-4-亞硝基哌嗪 |
|
詳細(xì)
|
Timolol |
噻嗎洛爾雜質(zhì)C |
610271-57-3 |
詳細(xì)
|
1H-1,3-Diazepine-4-carboxylicacid, 2-amino-4,5,6,7-tetrahydro-, (S)- (9CI) |
環(huán)L-精氨酸 |
28958-90-9 |
詳細(xì)
|
IMp. K (EP) |
氨芐西林EP雜質(zhì)K |
40610-41-1 |
詳細(xì)
|
NA |
3-甲基唑林類似物(USP雜質(zhì)h) |
|
詳細(xì)
|
Acetic acid, 2-[(3-amino-2-chloro-5-cyanophenyl)amino]-2-oxo- |
洛度沙胺雜質(zhì)A |
84944-23-0 |
詳細(xì)
|
4-(6-fluorobenzo[d]isoxazol-3-yl)-1-(2-(2-methyl-4-oxo-9-(palmitoyloxy)-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl)piperidine 1-oxide |
棕櫚酸帕利哌酮雜質(zhì)SYHF2036A-3201 |
1404053-60-6 |
詳細(xì)
|